Company
United StatesPublic company, NASDAQ: IBRXImmunityBio, Inc. (NASDAQ: IBRX), San Diego, CA – FDA Inspections
Inspection records and compliance data for ImmunityBio, Inc. in San Diego, CA. 1 FDA inspection on record, 1 Form 483, last inspected May 01, 2026. Publicly traded as NASDAQ: IBRX.
Company Profile
This profile covers ImmunityBio, Inc. based in San Diego, CA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected May 1, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 1, 2026 | Not classified | Human Drugs | 1321650 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
ImmunityBio, Inc.
Stock ticker
IBRX
Exchange
NASDAQ
Share price
$8.01
Market cap
$8.5B
Price as of
November 6, 2026
FEI Number
3020068662
Address
3530 John Hopkins Ct, San Diego, CA 92121-1121, United States
Country
United States
ID: 689f2cd3-37f9-41e8-8b4a-1c696270b755